Skip to main content
logo
Kintor Pharmaceutical Limited (HKG:9939)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.820
-0.070 (-3.70%)
Sep 18, 2026, 4:08 PM HKT

Kintor Pharmaceutical Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
78.7432.685--34.23
Revenue Growth
140.92%553.64%----
Gross Profit
33.98.041.48-1.13-34.23
Operating Income
-172.37-172.55-141.78-936.73-969.12-834.7
Net Income
-192.62-200.11-155.29-1,061-954.37-842.1
Earnings Per Share
-0.40-0.44-0.36-2.47-2.53-2.36
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
31.332.74147.42458.05876.961,057
Total Debt
133.5886.6133.01253.92286.39159.73
Net Cash (Debt)
-102.29-53.8614.41204.13590.57897
Net Cash Growth
---92.94%-65.43%-34.16%-23.43%
Net Cash Per Share
-0.21-0.120.030.481.572.52

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-150.91-169.74-199.08-387.58-961.26-1,051
Capital Expenditures
0.16-0.74-1.54-2.72-27.47-76.24
Free Cash Flow
-150.75-170.48-200.62-390.3-988.73-1,128
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
43.05%24.60%29.56%--100.00%
Operating Margin
-218.91%-527.96%-2835.64%---2438.42%
Pretax Margin
-251.75%-621.01%-3105.48%---2460.04%
Profit Margin
-244.63%-612.28%-3105.84%---2460.04%
FCF Margin
-191.46%-521.63%-4012.36%---3294.09%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-2.242.242.242.242.24
PS Ratio
9.8926.6078.93--113.46